Ajanta Pharma has announced the filing of the transcript for its earnings call held on November 3, 2025. The call discussed the company’s performance for the second quarter (Q2: Jul-Sep) of the financial year. The transcript is now available on the company’s website for investors and stakeholders to review, providing detailed insights into the company’s financial results and strategic outlook.
Earnings Call Transcript Available
Ajanta Pharma has released the written transcript of its earnings call, which took place on November 3, 2025. The earnings call covered the company’s financial and operational performance for the second quarter of the fiscal year (Q2: Jul-Sep).
Accessing the Transcript
The transcript is readily accessible on Ajanta Pharma’s official website. This document provides stakeholders with a detailed record of the discussions held during the call, including insights into financial results, strategic initiatives, and management’s outlook.
Purpose of the Announcement
This announcement ensures transparency and provides all interested parties with access to the information shared during the earnings call. The transcript serves as a valuable resource for understanding Ajanta Pharma’s performance and future strategies.
Source: BSE
